DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $825,000 | +7.8% | 2,711 | -4.9% | 0.11% | +21.1% |
| Q2 2021 | $765,000 | -5.7% | 2,851 | -20.9% | 0.09% | -3.2% |
| Q1 2021 | $811,000 | -22.2% | 3,605 | -23.1% | 0.09% | -21.2% |
| Q4 2020 | $1,042,000 | -32.4% | 4,689 | -28.9% | 0.12% | -36.6% |
| Q3 2020 | $1,542,000 | -23.3% | 6,593 | -42.0% | 0.19% | -26.2% |
| Q2 2020 | $2,010,000 | +38.2% | 11,366 | +8.2% | 0.25% | +18.3% |
| Q1 2020 | $1,454,000 | -24.2% | 10,503 | -15.9% | 0.21% | -4.5% |
| Q4 2019 | $1,917,000 | -14.7% | 12,489 | -19.8% | 0.22% | -6.7% |
| Q3 2019 | $2,248,000 | -14.4% | 15,566 | -15.3% | 0.24% | -13.7% |
| Q2 2019 | $2,626,000 | -17.6% | 18,378 | -23.9% | 0.28% | -63.0% |
| Q1 2019 | $3,188,000 | +54.3% | 24,152 | +20.6% | 0.75% | +49.6% |
| Q4 2018 | $2,066,000 | +249.0% | 20,033 | +268.1% | 0.50% | +331.0% |
| Q3 2018 | $592,000 | +4.6% | 5,442 | -5.1% | 0.12% | +2.7% |
| Q2 2018 | $566,000 | +11.2% | 5,732 | +10.1% | 0.11% | +5.6% |
| Q1 2018 | $509,000 | +5.6% | 5,206 | +0.3% | 0.11% | +13.8% |
| Q4 2017 | $482,000 | -36.8% | 5,192 | -41.6% | 0.09% | -31.9% |
| Q3 2017 | $763,000 | +5.2% | 8,894 | +3.5% | 0.14% | +5.3% |
| Q2 2017 | $725,000 | -56.4% | 8,594 | -55.8% | 0.13% | -48.2% |
| Q1 2017 | $1,663,000 | +9.8% | 19,445 | -0.0% | 0.25% | +8.1% |
| Q4 2016 | $1,514,000 | -31.1% | 19,451 | -30.6% | 0.23% | -20.1% |
| Q3 2016 | $2,198,000 | -13.8% | 28,033 | +11.1% | 0.29% | -7.9% |
| Q2 2016 | $2,550,000 | +14.9% | 25,241 | +7.9% | 0.32% | +17.8% |
| Q1 2016 | $2,220,000 | +1.5% | 23,403 | -0.6% | 0.27% | +20.5% |
| Q4 2015 | $2,187,000 | +4.5% | 23,553 | -4.1% | 0.22% | +6.7% |
| Q3 2015 | $2,092,000 | -0.3% | 24,548 | +0.2% | 0.21% | +16.7% |
| Q2 2015 | $2,098,000 | -1.5% | 24,505 | -2.3% | 0.18% | +1.7% |
| Q1 2015 | $2,129,000 | -5.9% | 25,073 | -5.1% | 0.18% | -5.9% |
| Q4 2014 | $2,263,000 | +1.6% | 26,410 | -9.9% | 0.19% | +4.4% |
| Q3 2014 | $2,227,000 | -17.8% | 29,312 | -14.8% | 0.18% | -16.7% |
| Q2 2014 | $2,708,000 | +8.4% | 34,393 | +3.2% | 0.22% | +18.7% |
| Q1 2014 | $2,499,000 | -6.5% | 33,319 | -3.8% | 0.18% | -12.9% |
| Q4 2013 | $2,674,000 | +13.9% | 34,650 | +2.3% | 0.21% | +10.0% |
| Q3 2013 | $2,348,000 | +10.4% | 33,861 | +0.8% | 0.19% | +4.4% |
| Q2 2013 | $2,127,000 | – | 33,603 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |